Information about the expected shortage of the medicinal product Androgel 50 mg, gel in unit-dose sachet
11.05.2012
The marketing authorisation holder for Androgel 50 mg, gel in unit-dose sachet, Abbott laboratories d.o.o., has informed the Agency for Medicinal Products and Medical Devices on the expected shortage of the medicinal product Androgel 50 mg, gel in unit-dose sachet (testosterone) on the Croatian market. The origin of the shortage is the termination of the Contract with the manufacturer Besins Manufacturing Belgium, Drogenbos, Belgium.
Untill the normalisation of supply of the Croatian market with the medicinal product Androgen, the Agency for Medicinal Products and Medical Devices will authorise the import of the product under the legal exemption scheme for patients need.
HALMED will make publicly available any new information on the availability of the medicinal product Androgen in due time.
